Geode Capital Management, LLC Anebulo Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 205,418 shares of ANEB stock, worth $336,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205,418
Previous 91,341
124.89%
Holding current value
$336,885
Previous $153,000
74.51%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANEB
# of Institutions
19Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$25.4 Million18.74% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$4.98 Million0.18% of portfolio
-
Mangrove Partners New York, NY2.53MShares$4.14 Million0.52% of portfolio
-
Morgan Stanley New York, NY399KShares$654,7190.0% of portfolio
-
Lvw Advisors, LLC350KShares$573,3710.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $42M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...